LQDA · Liquidia Corp · Documents
$35.93
+1.80 (+5.27%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$3.05B
Shares
89.51M
Volume · Oct 20
1.83M
Avg daily vol (3M)
3.1M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Liquidia Technologies, Inc. settled all ongoing litigation with United Therapeutics Corporation, will remove YUTREPIA’s PH-ILD indication, and will pay $175.0 million net plus $145.4 million; preliminary third quarter 2026 YUTREPIA net product sales were $222.7 million. | 2026-10-14 | 2026-10-08 | |
| 8-K | — | 2026-09-30 | — | |
| Investor Event Transcript | — | 2026-09-08 | 2026-09-30 | |
| 8-K | — | 2026-09-03 | — | |
| 8-K | — | 2026-08-12 | — | |
| 10-Q | — | 2026-08-12 | 2026-06-30 | |
| 8-K | — | 2026-06-17 | 2026-06-16 | |
| 8-K | — | 2026-06-08 | — | |
| Investor Event Transcript | — | 2026-06-03 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-05-13 | 2026-06-30 | |
| 10-Q | — | 2026-05-11 | 2026-03-31 | |
| 8-K | — | 2026-05-11 | — | |
| DEF 14A | — | 2026-04-24 | 2026-06-16 | |
| ARS | — | 2026-04-24 | 2025-12-31 | |
| DEFA14A | — | 2026-04-24 | — | |
| 10-K | — | 2026-03-05 | 2025-12-31 | |
| 8-K | — | 2026-03-05 | — | |
| S-3ASR | — | 2026-03-05 | — | |
| 8-K | — | 2026-01-09 | — | |
| 10-Q | — | 2025-11-03 | 2025-09-30 | |
| 8-K | — | 2025-11-03 | — | |
| 8-K | — | 2025-10-30 | 2025-10-27 | |
| 8-K | — | 2025-08-12 | — | |
| 10-Q | — | 2025-08-12 | 2025-06-30 | |
| 8-K | — | 2025-07-01 | — | |
| 8-K | — | 2025-06-24 | 2025-06-23 | |
| 8-K | — | 2025-06-18 | 2025-06-17 | |
| 8-K | — | 2025-06-18 | 2025-06-16 | |
| 8-K | — | 2025-06-02 | 2025-05-30 | |
| 8-K | — | 2025-05-23 | — | |
| 8-K | — | 2025-05-12 | 2025-05-09 | |
| 8-K | — | 2025-05-08 | 2024-12-31 | |
| 8-K | — | 2025-05-08 | — | |
| 10-Q | — | 2025-05-08 | 2025-03-31 | |
| 8-K | — | 2025-05-05 | 2025-05-02 | |
| ARS | — | 2025-04-25 | 2024-12-31 | |
| DEF 14A | — | 2025-04-25 | 2025-06-17 | |
| DEFA14A | — | 2025-04-25 | — | |
| 8-K | — | 2025-04-22 | 2025-04-21 | |
| 8-K | — | 2025-03-28 | — | |
| 10-K | — | 2025-03-19 | 2024-12-31 | |
| S-3 | — | 2025-03-19 | — | |
| 8-K | — | 2025-03-19 | — | |
| 8-K | — | 2025-03-18 | 2025-03-17 | |
| 8-K | — | 2025-02-28 | 2025-02-27 | |
| 8-K | — | 2024-11-26 | 2024-11-22 | |
| 8-K | — | 2024-11-13 | — | |
| 10-Q | — | 2024-11-13 | 2024-09-30 | |
| 8-K | — | 2024-10-07 | — | |
| 8-K | — | 2024-10-02 | — |
Showing 1–50 of 170 filings
Key facts
CIK
1819576
CUSIP
53635D202
13F (30d)
23 filings
23 filers
Visit website
Investor relations